Provider consultations The initial consultation is asynchronous and included with your plan
It mainly targets postprandial glucose
In the first study, the Authors observed that GLP-1 levels were similar in PCOS and controls in the early phase of the 75-g oral glucose tolerance test (OGTT) until 60 min, but that GLP-1 levels were significantly lower after 180 min, suggesting that women with PCOS might have reduced GLP-1 secretion in the late postprandial phase [45]
Serious problems appear less common in study reports, but persistent vomiting, dehydration, symptoms of low blood sugar, allergic reactions, or severe abdominal pain deserve prompt medical review
If diet and exercise haven't achieved the desired results, your healthcare provider might recommend one of the Food and Drug Administration (FDA)approved weight loss medications